GLP-1 weight-loss drugs Mounjaro and Zepbound have been removed from the Food and Drug Administration's (FDA) shortage list. ...
In a consultation the UK's drugs watchdog has now proposed the NHS expands its use for weight loss for those who are severely ...
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...
Ozempic and similar drugs are often effective because they produce feelings of satisfaction, in line with the NBC theory of ...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 569.58% and ...
The Alliance for Pharmacy Compounding shared an image with reporters of an Arlington, Va.-based pharmacist’s distribution ...